Next Article in Journal
Phylattrin, a New Cytotoxic Xanthone from Calophyllum soulattri
Previous Article in Journal
Preparative Isolation and Purification of Four Compounds from Cistanches deserticola Y.C. Ma by High-Speed Counter-Current Chromatography
Open AccessArticle

New Trifluoromethyl Triazolopyrimidines as Anti-Plasmodium falciparum Agents

1
Departamento de Síntese Orgânica, Instituto de Tecnologia em Fármacos-Farmanguinhos, Fundação Oswaldo Cruz, Manguinhos, Rio de Janeiro, RJ 21041-250, Brazil
2
Departamento de Química Orgânica, Instituto de Química, Universidade Federal do Rio de Janeiro, Cidade Universitária, Rio de Janeiro, RJ 21941-590, Brazil
3
Laboratório de Malária, Instituto de Pesquisas René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil
4
Programa de Pós Graduação em Medicina Molecular, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG 30000-000, Brazil
5
Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Campus do Valonguinho, Niterói, RJ 24020-141, Brazil
*
Author to whom correspondence should be addressed.
Molecules 2012, 17(7), 8285-8302; https://doi.org/10.3390/molecules17078285
Received: 31 May 2012 / Revised: 27 June 2012 / Accepted: 29 June 2012 / Published: 10 July 2012
(This article belongs to the Section Medicinal Chemistry)
According to the World Health Organization, half of the World’s population, approximately 3.3 billion people, is at risk for developing malaria. Nearly 700,000 deaths each year are associated with the disease. Control of the disease in humans still relies on chemotherapy. Drug resistance is a limiting factor, and the search for new drugs is important. We have designed and synthesized new 2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrimidine derivatives based on bioisosteric replacement of functional groups on the anti-malarial compounds mefloquine and amodiaquine. This approach enabled us to investigate the impact of: (i) ring bioisosteric replacement; (ii) a CF3 group substituted at the 2-position of the [1,2,4]triazolo[1,5-a]pyrimidine scaffold and (iii) a range of amines as substituents at the 7-position of the of heterocyclic ring; on in vitro activity against Plasmodium falciparum. According to docking simulations, the synthesized compounds are able to interact with P. falciparum dihydroorotate dehydrogenase (PfDHODH) through strong hydrogen bonds. The presence of a trifluoromethyl group at the 2-position of the [1,2,4]triazolo[1,5-a]pyrimidine ring led to increased drug activity. Thirteen compounds were found to be active, with IC50 values ranging from 0.023 to 20 µM in the anti-HRP2 and hypoxanthine assays. The selectivity index (SI) of the most active derivatives 5, 8, 11 and 16 was found to vary from 1,003 to 18,478. View Full-Text
Keywords: triazolopyrimidine; trifluoromethyl; malaria; P. falciparum; PfDHODH triazolopyrimidine; trifluoromethyl; malaria; P. falciparum; PfDHODH
Show Figures

Graphical abstract

MDPI and ACS Style

Boechat, N.; Pinheiro, L.C.S.; Silva, T.S.; Aguiar, A.C.C.; Carvalho, A.S.; Bastos, M.M.; Costa, C.C.P.; Pinheiro, S.; Pinto, A.C.; Mendonça, J.S.; Dutra, K.D.B.; Valverde, A.L.; Santos-Filho, O.A.; Ceravolo, I.P.; Krettli, A.U. New Trifluoromethyl Triazolopyrimidines as Anti-Plasmodium falciparum Agents. Molecules 2012, 17, 8285-8302.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop